top of page

UBE2N and Fatty Liver: A Mouse Study on How Liver Cells Clear Out Damaged Mitochondria

Writer: Joyce Knieff, NMD, LAc
Joyce Knieff, NMD, LAc
4 days ago
5 min read

Some people first hear about fatty liver from a line on an ultrasound report or a liver enzyme that came back a little high. The condition now goes by the name metabolic dysfunction-associated steatotic liver disease, or MASLD, and its inflamed, more serious form is called MASH. About 100 million Americans have MASLD, and an estimated 20% to 25% of them progress to MASH [2]. Researchers at Cedars-Sinai, working with collaborators in South Korea and elsewhere, studied why some fatty livers become inflamed and scarred [1, 2].


A fresh green salad with cherry tomatoes and sliced cucumber in a white bowl on a wooden kitchen board
Photo: Victoria Aleksandrova / Unsplash

What the UBE2N study found


UBE2N is an enzyme that attaches a specific kind of chemical tag to other proteins, which changes where those proteins go and what they do in the cell. The researchers found that UBE2N levels were lower in human and mouse liver cells affected by MASH [1].


They then studied mice whose liver cells could not make UBE2N. On a Western-style diet, those mice developed worse MASH and more scarring (fibrosis) [1]. In those mice, the liver cells were less able to clear out damaged mitochondria, which are the energy-producing parts of the cell. That cleanup process is called mitophagy. The cells also died more through a combined form of cell death the authors call PANoptosis [1]. When the researchers raised UBE2N levels in liver cells, these changes reversed and the liver returned toward normal function [1].


The mechanism involves a protein called p62. UBE2N tags p62 so that it can move into damaged mitochondria and mark them for removal. Without UBE2N, p62 builds up in the rest of the cell instead. When the researchers also deleted p62, the damage lessened, which suggests that the buildup caused the damage in these mice [1]. The authors describe p62 as a proof-of-concept treatment target [1]. All of the treatment experiments were done in mice and cells, and nothing in this study was tested as a therapy in people [1, 2].


What has helped fatty livers in people


The best-studied approaches for MASLD involve weight, diet, and physical activity. In a study of 293 people with biopsy-confirmed MASH who made lifestyle changes for a year, 90% of those who lost at least 10% of their body weight had their MASH resolve on a repeat biopsy, and 45% had less scarring [3]. Among people who lost at least 5%, MASH resolved in 58% [3]. Only 30% of participants reached that 5% mark, and the study had no comparison group, so the researchers could describe how weight loss related to liver changes but could not prove cause [3].


Exercise has been tested more directly. In a 2026 meta-analysis, researchers combined the results of 37 trials with 1,546 participants and found that both interval training and steady moderate exercise improved body composition, blood sugar and lipid measures, and liver markers, and about 83% of participants stuck with their programs [4]. A separate review of 11 randomized trials of resistance training found a modest drop in the liver enzyme ALT, and seven of the eight trials that imaged the liver found less liver fat [5].


Berberine, a plant compound, has also been studied. A 2024 meta-analysis of 10 randomized trials with 811 people with fatty liver found lower liver enzymes, lipids, and insulin resistance with berberine, and the side effects reported were mild and digestive [6]. Those trials measured blood markers and did not take liver biopsies.


Why the cell's recycling system is part of the fatty liver story


The name MASLD starts with metabolic dysfunction. In the UBE2N experiments, the researchers could see what that looks like inside a liver cell. Under the strain of a Western-style diet, cells that could not clear damaged mitochondria became inflamed and scarred [1]. Naturopathic doctors look first at the conditions those cells are living in, which is why weight loss and movement come before anything else. The UBE2N work concerns a step inside the cell, while diet and exercise change the load placed on it every day [3, 4].


Fatty liver is also connected to the rest of metabolism. Insulin resistance and blood lipids improved in the berberine trials [6], measures of heart and metabolic health improved with exercise [4], and those measures are part of the picture for anyone with MASLD.


Protecting your liver while UBE2N research stays in the lab


These steps are reasonable for anyone who has been told their liver has extra fat:


  1. A clear diagnosis comes first. If an ultrasound report mentioned fat in your liver or your liver enzymes came back high, your doctor can help confirm if MASLD is the right diagnosis and check if your risk of scarring has been assessed.

  2. Modest weight loss is associated with liver improvement. In the biopsy study, losing 5% of body weight was linked to better liver tissue, and 10% was linked to the largest changes [3]. Any plan for that should fit your body and your health history.

  3. Movement of almost any kind counts. Interval training, steady moderate exercise, and resistance training all improved liver measures in trials [4, 5], so the type you will keep doing is a sensible place to start.

  4. Check with your provider before starting a supplement. Berberine has trial data in fatty liver [6]. It also has biological effects of its own, so ask your provider if it is safe alongside any medications you take before you start.

  5. No UBE2N treatment exists yet. The researchers identified targets for future treatments, and testing in people would come later [1, 2].


References


  1. Wang F, Lee J, Park JS, ..., Roh YS, Seki E. UBE2N deficiency contributes to MASH development via p62-regulated mitophagy and PANoptosis. Nat Metab. 2026;8(9):1926-1947. PMID: 42698001. doi:10.1038/s42255-026-01590-0

  2. Original article (press coverage, secondary source): "This protective enzyme could help stop fatty liver disease from getting worse." ScienceDaily, October 2026. https://www.sciencedaily.com/releases/2026/10/261002080020.htm

  3. Vilar-Gomez E, Martinez-Perez Y, Calzadilla-Bertot L, et al. Weight loss through lifestyle modification significantly reduces features of nonalcoholic steatohepatitis. Gastroenterology. 2015;149(2):367-378. PMID: 25865049. doi:10.1053/j.gastro.2015.04.005

  4. Wang B, Zeng X, Deng H, et al. High-intensity interval training and moderate-intensity continuous training are effective, feasible, and safe for patients with metabolic dysfunction-associated steatotic liver disease (MASLD): a systematic review and meta-analysis. Metabolism. 2026;182:156677. PMID: 42297097. doi:10.1016/j.metabol.2026.156677

  5. Chen Y, Qiao X, Zou X, et al. Resistance training for metabolic dysfunction-associated steatotic liver disease: a systematic review and meta-analysis. Front Physiol. 2026;16:1679094. PMID: 41705123. doi:10.3389/fphys.2025.1679094

  6. Nie Q, Li M, Huang C, et al. The clinical efficacy and safety of berberine in the treatment of non-alcoholic fatty liver disease: a meta-analysis and systematic review. J Transl Med. 2024;22(1):225. PMID: 38429794. doi:10.1186/s12967-024-05011-2 (Yggdrasil abstract library)


This post is for education only and is not medical advice. Fatty liver disease needs individual evaluation, so please talk with your own provider before starting a weight-loss plan, a new exercise program, or any supplement.



If this resonates with what you're experiencing and you'd like to explore a naturopathic approach, book a consultation with our clinic.




 
 
 

Comments


bottom of page